All Relations between Muscle Weakness and dmd

Publication Sentence Publish Date Extraction Date Species
Kyriaki Kekou, Maria Svingou, Nikos Vogiatzakis, Evangelia Nitsa, Danai Veltra, Nikolaos M Marinakis, Faidon-Nikolaos Tilemis, Maria Tzetis, Anastasios Mitrakos, Charalambia Tsaroucha, Nicoletta Selenti, Giorgos-Konstantinos Papadimas, Constantinos Papadopoulos, Joanne Traeger-Synodinos, Hanns Lochmuller, Christalena Sofocleou. Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast heterogeneous DMD gene variants. Expert review of molecular diagnostics. 2023-09-27. PMID:37754746. retrospective analysis of persistent hyperckemia with or without muscle weakness in a case series from greece highlights vast heterogeneous dmd gene variants. 2023-09-27 2023-10-07 Not clear
Marcelo Dos Santos Voltani Lorena, Estela Kato Dos Santos, Renato Ferretti, G A Nagana Gowda, Guy L Odom, Jeffrey S Chamberlain, Cintia Yuri Matsumur. Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Skeletal muscle. vol 13. issue 1. 2023-09-13. PMID:37705069. dmd results in muscle weakness, loss of ambulation, and death at an early age. 2023-09-13 2023-10-07 mouse
Abdolvahab Ebrahimpour Gorji, Piotr Ostaszewski, Kaja Urbańska, Tomasz Sadkowsk. Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals? Biomedicines. vol 11. issue 8. 2023-08-26. PMID:37626825. duchenne muscular dystrophy (dmd) is an x-linked neuromuscular condition causing progressive muscle weakness and premature death. 2023-08-26 2023-09-07 mouse
Qiliang Xiong, Yuan Liu, Jieyi Mo, Yuxia Chen, Lianghong Zhang, Zhongyan Xia, Chen Yi, Shaofeng Jiang, Nong Xia. Gait asymmetry in children with Duchenne muscular dystrophy: evaluated through kinematic synergies and muscle synergies of lower limbs. Biomedical engineering online. vol 22. issue 1. 2023-07-31. PMID:37525241. in the context of duchenne muscular dystrophy (dmd), a disease characterized by progressive muscle weakness and joint contractures, previous studies have generally assumed symmetrical behavior of the lower limbs during gait. 2023-07-31 2023-08-14 Not clear
Boel De Paep. What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models. Biomedicines. vol 11. issue 7. 2023-07-29. PMID:37509672. duchenne muscular dystrophy (dmd), the severest form of muscular dystrophy, is characterized by progressive muscle weakness with fatal outcomes most often before the fourth decade of life. 2023-07-29 2023-08-14 mouse
Tetsushi Yamamoto, Yoshinori Nambu, Ryosuke Bo, Shotaro Morichi, Misato Yanagiya, Masafumi Matsuo, Hiroyuki Awan. Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy. Journal of cardiology. 2023-07-22. PMID:37481234. duchenne muscular dystrophy (dmd) is an inherited muscular disease characterized by progressive and fatal muscle weakness. 2023-07-22 2023-08-14 Not clear
Jeehyun Lee, Nia O Myrie, Gun-Jae Jeong, Woojin M Han, Young C Jang, Andrés J García, Stanislav Emeliano. In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy. Acta biomaterialia. 2023-07-15. PMID:37453552. statement of significance: in dmd patients, muscles experience cycles of regeneration and degeneration that contribute to chronic inflammation and muscle weakness. 2023-07-15 2023-08-14 mouse
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, Arnaud Ferr. Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and experimental pharmacology & physiology. 2023-06-29. PMID:37381823. the results of our study indicated that vpa in both murine dmd models reduced the susceptibility to contraction-induced functional loss but increased muscle weakness. 2023-06-29 2023-08-14 mouse
Adelina Balidemaj, Parmis Parsamanesh, Mykhailo Vysochy. Exploring the Dynamics of Caring for a Child With a Terminal Illness of Duchenne Muscular Dystrophy (DMD) and Its Copious Components on the Caregivers. Cureus. vol 15. issue 5. 2023-06-29. PMID:37384074. duchenne muscular dystrophy (dmd) is an inherited disorder that results in increasing muscle degeneration and muscle weakness because of a mutation in the dystrophin protein. 2023-06-29 2023-08-14 human
Thomas G George, Laurin M Hanft, Maike Krenz, Timothy L Domeier, Kerry S McDonal. Dystrophic cardiomyopathy: role of the cardiac myofilaments. Frontiers in physiology. vol 14. 2023-06-27. PMID:37362434. patients with dmd present with progressive skeletal muscle weakness and, because of treatment advances, a cardiac component of the disease (i.e., dystrophic cardiomyopathy) has been unmasked later in disease progression. 2023-06-27 2023-08-14 mouse
Norma P Tavakoli, Dorota Gruber, Niki Armstrong, Wendy K Chung, Breanne Maloney, Sunju Park, Julia Wynn, Carrie Koval-Burt, Lorraine Verdade, David H Tegay, Lilian L Cohen, Natasha Shapiro, Annie Kennedy, Garey Noritz, Emma Ciafaloni, Barry Weinberger, Marty Ellington, Charles Schleien, Regina Spinazzola, Sunil Sood, Amy Brower, Michele Lloyd-Puryear, Michele Caggan. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Annals of clinical and translational neurology. 2023-06-23. PMID:37350320. duchenne muscular dystrophy (dmd) is an x-linked disorder resulting in progressive muscle weakness and atrophy, cardiomyopathy, and in late stages, cardiorespiratory impairment, and death. 2023-06-23 2023-08-14 Not clear
Kasun Kodippili, Michael A Rudnick. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Frontiers in physiology. vol 14. 2023-06-16. PMID:37324396. progressive muscle weakness and degeneration characterize duchenne muscular dystrophy (dmd), a lethal, x-linked neuromuscular disorder that affects 1 in 5,000 boys. 2023-06-16 2023-08-14 Not clear
Jae-Sung You, Yongdeok Kim, Soohyun Lee, Rashid Bashir, Jie Che. RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice. Journal of cachexia, sarcopenia and muscle. 2023-06-13. PMID:37311604. duchenne muscular dystrophy (dmd), caused by dystrophin deficiency, leads to progressive and fatal muscle weakness through yet-to-be-fully deciphered molecular perturbations. 2023-06-13 2023-08-14 mouse
Krzysztof Zabłocki, Dariusz C Góreck. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies. International journal of molecular sciences. vol 24. issue 11. 2023-06-11. PMID:37298386. the most severe, common types are duchenne muscular dystrophy (dmd) and limb-girdle sarcoglycanopathy, which cause advancing muscle weakness and wasting. 2023-06-11 2023-08-14 mouse
Audrey S Chan, Justin P Hardee, Martha Blank, Ellie H-J Cho, Narelle E McGregor, Natalie A Sims, Gordon S Lync. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in Journal of applied physiology (Bethesda, Md. : 1985). 2023-06-01. PMID:37262103. as dmd patients also develop bone fragility because of muscle weakness and immobilization, better understanding the pathophysiological mechanisms of dystrophin deficiency will help develop therapies to improve musculoskeletal health. 2023-06-01 2023-08-14 mouse
Andreas C Chai, Francesco Chemello, Hui Li, Takahiko Nishiyama, Kenian Chen, Yu Zhang, Efraín Sánchez-Ortiz, Adeeb Alomar, Lin Xu, Ning Liu, Rhonda Bassel-Duby, Eric N Olso. Single-swap editing for the correction of common Duchenne muscular dystrophy mutations. Molecular therapy. Nucleic acids. vol 32. 2023-05-23. PMID:37215149. duchenne muscular dystrophy (dmd) is a fatal x-linked recessive disease of progressive muscle weakness and wasting caused by the absence of dystrophin protein. 2023-05-23 2023-08-14 human
Dongwoo Hahn, Joseph D Quick, Brian R Thompson, Adelyn Crabtree, Benjamin J Hackel, Frank S Bates, Joseph M Metzge. Rapid restitution of contractile dysfunction by synthetic copolymers in dystrophin-deficient single live skeletal muscle fibers. Skeletal muscle. vol 13. issue 1. 2023-05-19. PMID:37208786. dmd patients develop severe skeletal muscle weakness, degeneration, and early death. 2023-05-19 2023-08-14 mouse
Amritharekha Nayak, Apoorva S B, Mainak Bardhan, R Rashmi, G Arunachal, P V Prathyusha, Atchayaram Nalini, T N Sathyaprabha, Kaviraja Udup. Evaluation of Cardiac, Autonomic Functions in Ambulant Patients with Duchenne Muscular Dystrophy. SN comprehensive clinical medicine. vol 5. issue 1. 2023-05-16. PMID:37193318. duchenne muscular dystrophy (dmd) is an x-linked genetic disorder caused by dystrophin gene mutation resulting in muscle weakness, motor delays, difficulty in standing, and inability to walk by 12 years. 2023-05-16 2023-08-14 Not clear
Nao Yamauchi, Katsuyuki Tamai, Iori Kimura, Azuma Naito, Nao Tokuda, Yuki Ashida, Norio Motohashi, Yoshitsugu Aoki, Takashi Yamad. High-intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin-deficient muscle. The Journal of physiology. 2023-05-15. PMID:37184335. duchenne muscular dystrophy (dmd) is a genetic muscle-wasting disorder characterised by progressive muscle weakness and easy fatigability. 2023-05-15 2023-08-14 mouse
Giulia Beltrame, Alessandro Scano, Giorgia Marino, Andrea Peccati, Lorenzo Molinari Tosatti, Nicola Portinar. Recent developments in muscle synergy analysis in young people with neurodevelopmental diseases: A Systematic Review. Frontiers in bioengineering and biotechnology. vol 11. 2023-05-14. PMID:37180039. considering dmd, no correlation was found between non-neural muscle weakness and muscle modules' variation, while in chronic pain a decreased number of synergies was observed as a possible consequence of plastic adaptations. 2023-05-14 2023-08-14 Not clear